JOINT FILING STATEMENTJoint Filing Agreement • February 14th, 2017 • Dievini Hopp BioTech Holding GmbH & Co KG • Pharmaceutical preparations
In accordance with Rule 13d-1(k) under the Securities Exchange Act of 1934, as amended, each of the undersigned hereby agree to the joint filing on behalf of each of them of a statement on Schedule 13G (including amendments thereto) with respect to the common shares of AC Immune SA and further agree that this Joint Filing Agreement be included as an exhibit to such joint filing.
